Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.

about

Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.

Item

http://www.wikidata.org/entity/Q41159933

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.

@en

type

Item

label

Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.

@en

prefLabel

Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.

@en

P1476

Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.

@en

P2093

A Bennett

http://www.w3.org/2001/XMLSchema#string

A Tovmasyan

http://www.w3.org/2001/XMLSchema#string

A W Beaven

http://www.w3.org/2001/XMLSchema#string

D A Rizzieri

http://www.w3.org/2001/XMLSchema#string

I Batinic-Haberle

http://www.w3.org/2001/XMLSchema#string

I Spasojevic

http://www.w3.org/2001/XMLSchema#string

K G Berman

http://www.w3.org/2001/XMLSchema#string

M L Hauck

http://www.w3.org/2001/XMLSchema#string

M W Dewhirst

http://www.w3.org/2001/XMLSchema#string

R S Sampaio

http://www.w3.org/2001/XMLSchema#string

P2860

Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways

Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model

Spontaneously occurring tumors of companion animals as models for human cancer.

Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.

Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.

Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.

Radioprotection of the brain white matter by Mn(III) n-Butoxyethylpyridylporphyrin-based superoxide dismutase mimic MnTnBuOE-2-PyP5+.

Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.

A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.

P2888

s00280-017-3372-z

P304

421-431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-017-3372-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M K Boss

P577

2017-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090367750

http://www.w3.org/2001/XMLSchema#string

P698

28685347

http://www.w3.org/2001/XMLSchema#string

P932

5532403

http://www.w3.org/2001/XMLSchema#string